A carregar...
Anti-resorptive therapy for preventing bone loss: When to use one or two anti-resorptive agents?
Women who have significant bone loss or a new fracture on monotherapy are considered for combination therapy. Combination therapies increases bone density more than mono-therapy by targeting different parts of the osteoclast pathway. In early post-menopausal women who are symptomatic the use of comb...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4140184/ https://ncbi.nlm.nih.gov/pubmed/24036481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GRF.0b013e3182a982c2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|